期刊文献+

氯霉素地塞米松搽剂的制备及其临床应用 被引量:1

Preparation and clinical application of chloramphenicol and dexamethasone liniment
下载PDF
导出
摘要 目的介绍氯霉素地塞米松搽剂的制备,及其在轻中度寻常痤疮中的疗效。方法制备氯霉素地塞米松搽剂,并对其进行质量控制。分析其与氯霉素搽剂在轻中度寻常痤疮治疗过程中的临床疗效。结果本品制作简便,质量符合《中国药典》要求,与氯霉素搽剂比较,本品对轻中度寻常痤疮的治疗疗效更佳、不良反应更少。结论本品制备工艺可靠,质量可控,对轻中毒寻常痤疮的治疗疗效佳,不良反应少,是寻常痤疮治疗的好选择。 A/M To introduce the preparation of chloramphenicol and dexamethasone liniment, and evaluate the efficacy of it in the treatment of mild to moderate acne vulgaris patients. METHODS The chlorarnphenicol and dexamethasone liniment was prepared; its quality was controlled. The efficacy of chloramphenicol and dexamethasone liniment was evaluated in the treatment of mild to moderate acne vulgaris patients. RESULTS The manufacturing technology of this product was simple and its quality was in accord with require of Pharmacopoeia of The People' s Republic of China. "me efficacy of it in the treatment of mild to moderate acne vulgaris patients was better and adverse drug reaction was less than chloramphenicol liniment. CONCLUSION The manufacturing technology of this product is reliable and its quality can be controlled. The efficacy of it in the treatment of mild to moderate acne vulgaris patients is good and its adverse drug reaction is little. This product will be a good choice in the treatment of acne vulgaris
出处 《中国临床药学杂志》 CAS 2006年第6期379-381,共3页 Chinese Journal of Clinical Pharmacy
关键词 氯霉素地塞米松搽剂 寻常痤疮 氯霉素搽剂 ehloramphenieol and dexamethasone liniment aene vulgaris ehloramphenieol liniment
  • 相关文献

参考文献4

二级参考文献8

共引文献54

同被引文献18

  • 1王明丽,胡祥珍.复方地塞米松软膏的制备及临床应用[J].苏州大学学报(医学版),2006,26(2):232-235. 被引量:3
  • 2Bang OY. Intraeranial Atherosclerosis: Current Understanding and Perspectives. Journal of stroke, 2014,16:27-35.
  • 3Arjmand Shabestari A. Coronary Artery Calcium Score: A Re- view. Iranian Red Crescent medical i ournal, 2013,15: e16616.
  • 4Toutouzas K, Synetos A, Nikolaou C, et al. Microwave radiom- etry: A new non-invasive method for the detection of vulnera- ble plaque. Cardiovascular diagnosis and therapy, 2012,2 : 290- 297.
  • 5Tokunaga F. Linear ubiquitination-mediated NF-kappaB regu- lation and its related disorders. Journal of biochemistry, 2013, 154:313-23.
  • 6Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Molecular cancer,2013, 12:86.
  • 7May P. The low-density lipoprotein receptor-related protein 1 in inflammation. Current opinion in lipidology, 2013, 24: 134- 137.
  • 8Phillips MI,Kagiyama S. Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs, 2002,3 : 569-577.
  • 9Goldminz AM, Au SC,Kim N, et al. NF-kappaB: An essential transcription factor in psoriasis. Journal of dermatological sci- ence, 2013,69:89-94.
  • 10Ling J, Kumar R. Crosstalk between NFkB and glucocortieoid signaling:A potential target of breast cancer therapy. Cancer letters, 2012,322,119-26.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部